The role of microvesicles derived from mesenchymal stem cells in tissue regeneration; A dream for tendon repair?

Muscles, Ligaments and Tendons Journal

Volumn 2, Issue 3, 2012, Pages 212-221

  Tetta, Ciro ^a   Consiglio, Anna Lange ^b   Bruno, Stefania ^c   Tetta, Emanuele ^d   Gatti, Emanuele ^a   Dobreva, Miryana ^a   Cremonesi, Fausto ^b   Camussi, Giovanni ^e  

^a Fresenius Medical Care   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

Author keywords

Horse tendinopathies; Microvesicles; Regenerative medicine; Soluble factors; Stem cells

Indexed keywords

EID: 84892843829     PISSN: None     EISSN: 22404554     Source Type: Journal    
DOI: None     Document Type: Review

References (97)

1. Kraus KH, Kirker-Head C. Mesenchymal stem cells and bone regeneration. Vet Surg 2006;35:232-242.
2. Brehm W, Aklin B, Yamashita T et al. Repair of superficial osteochondral defects with an autologous scaffold-free cartilage construct in a caprine model: implantation method and short-term results. Osteoarthritis Cartilage 2006;14:1214-1226.
3. Wilke MM, Nydam DV, Nixon AJ. Enhanced early chondrogenesis in articular defects following arthroscopic mesenchymal stem cell implantation in an equine model. J Orthop Res 2007;25:913-925.
4. Méndez-Ferrer S, Michurina TV, Ferraro F et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010;466:829-834.
5. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006;98:1076-1084.
6. Yagi H, Soto-Gutierrez A, Parekkadan B et al. Mesenchymal stem cells: Mechanisms of immunomodulation and homing. Cell Transplant 2010;19:667-679.
7. Amado LC, Saliaris AP, Schuleri KH et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A 2005;102:11474-11279.
8. Morigi M, Imberti B, Zoja C et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 2004;15:1794-1804.
9. Morigi M, Introna M, Imberti B et al. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells 2008;26:2075-2082.
10. Herrera MB, Bussolati B, Bruno S, Fonsato V, Romanazzi GM, Camussi G. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med 2004;14:1035-1041.
11. Herrera MB, Bussolati B, Bruno S et al. Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int 2007;72:430-441.
12. Duffield JS, Park KM, Hsiao LL et al. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrowderived stem cells. J Clin Invest 2005;115:1743-1755.
13. Choi S, Park M, Kim J, Hwang S, Park S, Lee Y. The role of mesenchymal stem cells in the functional improvement of chronic renal failure. Stem Cells Dev 2009;18:521-529.
14. Yamada M, Kubo H, Kobayashi S et al. Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury. J Immunol 2004;172:1266-1272.
15. Rojas M, Xu J, Xu J et al. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 2005;33:145-152.
16. Ortiz LA, Dutreil M, Fattman C et al. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci U S A 2007;104:11002-11007.
17. Bi B, Ehirchiou D, Kilts TM et al. Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol 2007;18:2486-2496.
18. Parekkadan B, van Poll D, Suganuma K et al. Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS One 2007;2:e941
19. van Poll D, Parekkadan B, Cho CH et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 2008;47:1634-1643.
20. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003;75:389-397.
21. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105:1815-1822.
22. Di Nicola M, Carlo-Stella C, Magni M et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002;99:3838-3843.
23. Meisel R, Zibert A, Laryea M, Göbel U, Däubener W, Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 2004;103:4619-4621.
24. Djouad F, Charbonnier LM, Bouffi C et al. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells 2007;25:2025-2032.
25. Chen L, Zhang W, Yue H et al. Effects of human mesenchymal stem cells on the differentiation of dendritic cells from CD34+ cells. Stem Cells Dev 2007;16:719-731.
26. Oliva F, Giai Via A, Maffulli N. Physiopathology of intratendinous calcific deposition. BMC Med 2012; 23;10:95.
27. Fenwick Sea. Endochondral ossification in Achilles and patella tendinopathy. Rheumatology 2002;41:474-476.
28. Salingcarnboriboon R, Yoshitake H, Tsuji K et al. Establishment of tendon-derived cell lines exhibiting pluripotent mesenchymal stem cell-like property. Exp Cell Res 2003;287:289-300.
29. de Mos M, Koevoet WJ, Jahr H et al. Intrinsic differentiation potential of adolescent human tendon tissue: an in-vitro cell differentiation study. BMC Musculoskelet Disord 2007;8:16.
30. Seo BM, Miura M, Gronthos S et al. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 2004;364:149-155.
31. Bi Y, Ehirchiou D, Kilts TM et al. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med 2007;13:1219-1227.
32. Lovati AB, Corradetti B, Lange Consiglio A et al. Characterization and differentiation of equine tendonderived progenitor cells. J Biol Regul Homeost Agents 2011;25:S75-84.
33. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all postnatal organs and tissues. J Cell Sci 2006;119:2204-2213.
34. Hunter W. Of the structure and disease of articulating cartilages. 1743. Clin Orthop Relat Res 1995;(317):3-6.
35. Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 2000;113:1161-1166.
36. Kajikawa Y, Morihara T, Watanabe N et al. GFP chimeric models exhibited a biphasic pattern of mesenchymal cell invasion in tendon healing. J Cell Physiol 2007;210:684-691.
37. Williams IF, Heaton A, McCullagh KG. Cell morphology and collagen types in equine tendon scar. Res Vet Sci 1980;28:302-310.
38. Kryger GS, Chong AK, Costa M, Pham H, Bates SJ, Chang J. A comparison of tenocytes and mesenchymal stem cells for use in flexor tendon tissue engineering. J Hand Surg Am 2007;32:597-605.
39. Liu W, Chen B, Deng D, Xu F, Cui L, Cao Y. Repair of tendon defect with dermal fibroblast engineered tendon in a porcine model. Tissue Eng 2006;12:775-788.
40. Evans CE, Trail IA. An in vitro comparison of human flexor and extensor tendon cells. J Hand Surg Br 2001;26:307-313.
41. Young RG, Butler DL, Weber W, Caplan AI, Gordon SL, Fink DJ. Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res 1998;16:406-413.
42. Awad HA, Butler DL, Boivin GP et al. Autologous mesenchymal stem cell-mediated repair of tendon. Tissue Eng 1999;5:267-277.
43. Awad HA, Boivin GP, Dressler MR, Smith FN, Young RG, Butler DL. Repair of patellar tendon injuries using a cell-collagen composite. J Orthop Res 2003;21:420-431.
44. Juncosa-Melvin N, Matlin KS, Holdcraft RW, Nirmalanandhan VS, Butler DL. Mechanical stimulation increases collagen type I and collagen type III gene expression of stem cell-collagen sponge constructs for patellar tendon repair. Tissue Eng 2007;13:1219-1226.
45. Butler DL, Juncosa-Melvin N, Boivin GP et al. Functional tissue engineering for tendon repair: A multidisciplinary strategy using mesenchymal stem cells, bioscaffolds, and mechanical stimulation. J Orthop Res 2008;26:1-9.
46. Hankemeier S, Keus M, Zeichen J et al. Modulation of proliferation and differentiation of human bone marrow stromal cells by fibroblast growth factor 2: potential implications for tissue engineering of tendons and ligaments. Tissue Eng 2005;11:41-49.
47. Hankemeier S, van Griensven M, Ezechieli M et al. Tissue engineering of tendons and ligaments by human bone marrow stromal cells in a liquid fibrin matrix in immunodeficient rats: results of a histologic study. Arch Orthop Trauma Surg 2007;127:815-821.
48. Alves AGL, Stewart AA, Dudhia J, Kasashima Y, Goodship AE, Smith RKW. Cell-based therapies for tendon and ligament injuries. Vet Clin North Am Equine Pract 2011;27:315-333.
49. Smith RK, Korda M, Blunn GW, Goodship AE. Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment. Equine Vet J 2003;35:99-102.
50. Brehm W, Burk J, Delling U, Gittel C, Ribitsch I. Stem cell-based tissue engineering in veterinary orthopaedics. Cell Tissue Res 2012;347:677-688.
51. Richardson LE, Dudhia J, Clegg PD, Smith R. Stem cells in veterinary medicine-attempts at regenerating equine tendon after injury. Trends Biotechnol 2007;25:409-416.
52. Chong AK, Chang J, Go JC. Mesenchymal stem cells and tendon healing. Front Biosci 2009;14:4598-4605.
53. Fortier LA, Travis AJ. Stem cells in veterinary medicine. Stem Cell Res Ther 2011;2:9.
54. Al-Sadi O, Schulze-Tanzil G, Kohl B et al. Tenocytes, pro-inflammatory cytokines and leukocytes: a relationship? MLTJ 2011;1:68-76.
55. Herrero C, Pérez-Simón JA. Immunomodulatory effect of mesenchymal stem cells. Braz J Med Biol Res 2010;43:425-430.
56. Ren G, Zhang L, Zhao X et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2008;2:141-150.
57. Guest DJ, Smith MR, Allen WR. Monitoring the fate of autologous and allogeneic mesenchymal progenitor cells injected into the superficial digital flexor tendon of horses: preliminary study. Equine Vet J 2008;40:178-181.
58. Nixon AJ, Dahlgren LA, Haupt JL, Yeager AE, Ward DL. Effect of adipose-derived nucleated cell fractions on tendon repair in horses with collagenase-induced tendinitis. Am J Vet Res 2008;69:928-937.
59. Schnabel LV, Lynch ME, van der Meulen MC, Yeager AE, Kornatowski MA, Nixon AJ. Mesenchymal stem cells and insulin-like growth factor-I gene-enhanced mesenchymal stem cells improve structural aspects of healing in equine flexor digitorum superficialis tendons. J Orthop Res 2009;27:1392-1398.
60. Smith R, Young N, Dudhia J, Kasashima Y, Clegg P, Goodship A. Effectiveness of bone-marrow-derived mesenchymal progenitor cells for naturally occurring tendinopathy in the horse. Regen Med 2009;4:S25-26.
61. Crovace A, Lacitignola L, Rossi G, Francioso E. Histological and immunohistochemical evaluation of autologous cultured bone marrow mesenchymal stem cells and bone marrow mononucleated cells in collagenase-induced tendinitis of equine superficial digital flexor tendon. Vet Med Int 2010;2010:250978.
62. Smith RK, Zunino L, Webbon PM, Heinegård D. The distribution of cartilage oligomeric matrix protein (COMP) in tendon and its variation with tendon site, age and load. Matrix Biol 1997;16:255-271.
63. Leppänen M, Miettinen S, Mäkinen S et al. Management of equine tendon & ligament injuries with expanded autologous adipose-derived mesenchymal stem cells: a clinical study, Regen Med 2009b;4: S21.
64. Pacini S, Spinabella S, Trombi L et al. Suspension of bone marrow-derived undifferentiated mesenchymal stromal cells for repair of superficial digital flexor tendon in race horses. Tissue Eng 2007;13:2949-2955.
65. Smith RK. Mesenchymal stem cell therapy for equine tendinopathy. Disabil Rehabil 2008;30:1752-1758.
66. Burk J, Brehm W. Stammzellentherapie von Sehnenverletzungen-klinische Ergebnisse von 98 Fällen. Pferdeheilkunde 2011;153-161.
67. Del Bue M, Ricco S, Ramoni R et al. Equine adiposetissue derived mesenchymal stem cells and platelet concentrates: their association in vitro and in vivo. Vet Res Commun 2008;Suppl1:S51-S55.
68. Dahlgren LA. Fat-derived mesenchymal stem cells for equine tendon repair. Regen Med 2009;4Suppl. 2: S14.
69. Leppänen M, Heikkilä P, Katiskalahti T, Tulamo RM. Followup of recovery of equine tendon & ligament injuries 18-24 months after treatment with enriched autologous adipose-derived mesenchymal stem cells: a clinical study. Reg Med 2009a;4:S21-22.
70. Crovace A, Lacitignola L, De Siena R et al. Cell therapy for tendon repair in horses: an experimental study. Vet Res Commun 2007;31 Suppl 1:281-283.
71. Lacitignola L, Crovace A, Rossi G, Francioso E. Cell therapy for tendinitis, experimental and clinical report. Vet Res Commun 2008;S33-S38.
72. Lange-Consiglio A, Corradetti B, Bizzaro D et al. Characterization and potential applications of progenitor-like cells isolated from horse amniotic membrane. J Tissue Eng Regen Med 2012;6:622-635.
73. Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006;20:1487-1495.
74. Camussi G, Deregibus MC, Bruno S, Cantaluppi V, Biancone L. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 2010;78:838-848.
75. Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol 2009;19:43-51.
76. Quesenberry PJ, Aliotta JM. The paradoxical dynamism of marrow stem cells: considerations of stem cells, niches, and microvesicles. Stem Cell Rev 2008; 4:137-147.
77. Aliotta JM, Pereira M, Johnson KW, et al. Microvesicle entry into marrow cells mediates tissue-specific changes in mRNA by direct delivery of mRNA and induction of transcription. Exp Hematol 2010; 38:233-245.
78. Deregibus MC, Cantaluppi V, Calogero R et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood. 2007; 110:2440-2448.
79. Collino F, Deregibus MC, Bruno S et al. Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS One. 2010, 27;5(7):e11803.
80. Collino F, Bruno S, Deregibus MC, Tetta C, Camussi G. MicroRNAs and mesenchymal stem cells. Vitam Horm. 2011;87:291-320.
81. Bruno S, Grange C, Deregibus MC et al. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 2009;20:1053-1067.
82. Gatti S, Bruno S, Deregibus MC et al. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant 2011;26:1474-1483.
83. Bruno S, Grange C, Collino F et al. Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. PLoS One. 2012;7:e33115.
84. Lai RC, Arslan F, Lee MM et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 2010;4:214-222.
85. Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 1999;94:3791-3799.
86. Dahlgren LA, van der Meulen MC, Bertram JE, Starrak GS, Nixon AJ. Insulin-like growth factor-I improves cellular and molecular aspects of healing in a collagenase-induced model of flexor tendinitis. J Orthop Res 2002;20:910-919.
87. Godwin EE, Young NJ, Dudhia J, Beamish IC, Smith RK. Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon. Equine Vet J 2012;44:25-32.
88. Paris DB, Stout TA. Equine embryos and embryonic stem cells: defining reliable markers of pluripotency. Theriogenology 2010;74:516-524.
89. Corradetti B, Lange-Consiglio A, Barucca M, Cremonesi F, Bizzaro D. Size-sieved subpopulations of mesenchymal stem cells from intervascular and perivascular equine umbilical cord matrix. Cell Prolif 2011;44:330-342.
90. Carrade DD, Owens SD, Galuppo LD et al. Clinicopathologic findings following intra-articular injection of autologous and allogeneic placentally derived equine mesenchymal stem cells in horses. Cytotherapy 2011;13:419-430.
91. Fortier LA, Potter HG, Rickey EJ et al. Concentrated bone marrow aspirate improves full-thickness cartilage repair compared with microfracture in the equine model. J Bone Joint Surg Am 2010;92:1927-1937.
92. Alderman D, Alexander RW. Advancements in stem cell therapy: application to veterinary medicine. Today's Veterinary Practice July/August 2011.
93. Durando MM, Zarucco L, Schaer TP, Ros, M, Reef VB. Pneumopericardium in a horse secondary to sternal bone marrow aspiration. Equine vet Educ 2006;18:75-79.
94. Vidal MA, Kilroy GE, Lopez MJ et al. Characterization of equine adipose tissue-derived stromal cells: adipogenic and osteogenic capacity and comparison with bone marrow-derived mesenchymal stromal cells. Vet Surg 2007;36:613-622.
95. Vidal MA, Walker NJ, Napoli E, Borjesson DL. Evaluation of senescence in mesenchymal stem cells isolated from equine bone marrow, adipose tissue, and umbilical cord tissue. Stem Cells Dev 2012;21:273-283.
96. Vidal MA, Kilroy GE, Lopez MJ, Johnson JR, Moore RM, Gimble JM. Characterization of equine adipose tissue-derived stromal cells: adipogenic and osteogenic capacity and comparison with bone marrowderived mesenchymal stromal cells. Vet Surg 2007;36:613-622.
97. Colleoni S, Bottani E, Tessaro I et al. Isolation, growth and differentiation of equine mesenchymal stem cells: effect of donor, source, amount of tissue and supplementation with basic fibroblast growth factor. Vet Res Commun 2009;33:811-821.